key: cord-0727870-mjlx97ci
authors: Devi, Yengkhom Damayanti; Devi, Arpita; Gogoi, Hemanga; Dehingia, Bondita; Doley, Robin; Buragohain, Alak Kumar; Singh, Ch. Shyamsunder; Borah, Partha Pratim; Rao, C.Durga; Ray, Pratima; Varghese, George M.; Kumar, Sachin; Namsa, Nima D.
title: Exploring rotavirus proteome to identify potential B- and T-cell epitope using computational immunoinformatics
date: 2020-12-29
journal: Heliyon
DOI: 10.1016/j.heliyon.2020.e05760
sha: d00db65ee4ea6b0cfc37494dc72e2e34320addb1
doc_id: 727870
cord_uid: mjlx97ci

Rotavirus is the most common cause of acute gastroenteritis in infants and children worldwide. The functional correlation of B- and T-cells to long-lasting immunity against rotavirus infection in the literature is limited. In this work, a series of computational immuno-informatics approaches were applied and identified 28 linear B-cells, 26 conformational B-cell, 44 T(C) cell and 40 T(H) cell binding epitopes for structural and non-structural proteins of rotavirus. Further selection of putative B and T cell epitopes in the multi-epitope vaccine construct was carried out based on immunogenicity, conservancy, allergenicity and the helical content of predicted epitopes. An in-silico vaccine constructs was developed using an N-terminal adjuvant (RGD motif) followed by T(C) and T(H) cell epitopes and B-cell epitope with an appropriate linker. Multi-threading models of multi-epitope vaccine construct with B- and T-cell epitopes were generated and molecular dynamics simulation was performed to determine the stability of designed vaccine. Codon optimized multi-epitope vaccine antigens was expressed and affinity purified using the E. coli expression system. Further the T cell epitope presentation assay using the recombinant multi-epitope constructs and the T cell epitope predicted and identified in this study have not been investigated. Multi-epitope vaccine construct encompassing predicted B- and T-cell epitopes may help to generate long-term immune responses against rotavirus. The computational findings reported in this study may provide information in developing epitope-based vaccine and diagnostic assay for rotavirus-led diarrhea in children's.

Rotavirus is the most common cause of acute gastroenteritis in infants and children worldwide. As per WHO reports of 2013 about 215 000 children under five-years of age die annually due to rotavirus infections mainly in low-income countries [1] . Rotavirus particles naturally excreted in the stools of infected children are transmitted mainly through the fecal-oral route, close-contact and fomites [2] . Rotaviruses are nonenveloped RNA viruses and belongs to the family Reoviridae. The mature infectious rotavirus particles is made up of three layers of capsid proteins: outer (proteins VP7 and VP4), middle (protein VP6), and inner (protein VP2). The dsRNA genome of rotavirus encodes for 6 structural proteins and 6 non-structural proteins [3] . Rotavirus infectivity is enhanced by cleavage of VP4 protein into two fragments, VP5* (facilitates cell membrane penetration) and VP8* (mediates cell attachment) [4] . Rotavirus VP4 and VP7 proteins that are commonly used for serotyping are equally important for vaccine development due to development of neutralizing antibodies to VP7, VP8*, and VP5* during natural rotavirus infection [5] . Rotavirus is further divided into nine serogroups (A-I) based on group specific viral antigen VP6 [6] .

Vaccination is considered the most reliable preventive measure to avoid serious consequences of rotaviral gastroenteritis that can even lead to death. Two oral live attenuated rotavirus vaccines (Rotarix (monovalent, GSK Biologicals) and RotaTeq (pentavalent bovine-human reassortant, Merck) were available in the year 2006 for Indian children immunization [7, 8] . The effectiveness of Rotarix® and RotaTeq® in high-and middle-income countries were observed high ranging from 85% to 98% [9, 10] . However, average efficacies (51%-64%) were found in the low-income Asian and African countries [11, 12] . Rotavac™ (Bharat Biotech, Hyderabad, a bovine-human reassortant neonatal 116E strain (G9P [11] ) and RotaSiil™ (Serum Institute of India Pvt. Ltd., Pune, a bovine-human reassortant with human G1, G2, G3 and G4 bovine UK G6P [5] backbone) are two Indian-produced live-attenuated oral RV vaccines that are found effective in preventing rotavirus-induced gastroenteritis [13] . The efficacy and effectiveness for Rotavac™ against severe gastroenteritis during the first year of life was 56% [14] and 49% in the subsequent year [15] . RotaSiil is a heat-stable oral vaccine that can retain stability up to 18 months during storage at 40 C [16] . The vaccine efficacy against severe rotavirus gastroenteritis in an immunized Indian children was 33% [17] and 67% in Niger [18] . The results of an Indian manufactured vaccines showed similar efficacy with the existing commercial vaccines for rotavirus in developing country populations. Live-attenuated strains of RV vaccines have the inherent potential to interchange genetic materials with the circulating strains that might generate a virulent RV strains [19] . Although at a lower rate, live-attenuated oral RV vaccines are associated with the risk of developing intussusception (IS) [20, 21] in an age-dependent manner [22, 23] . An estimated of about 1-6 cases of IS during the administration of first or second dose for Rotarix® and RotaTeq® per 100,000 immunized children have been reported [20] . Similar rates of IS have been observed for an Indian manufactured vaccines, Rotavac® [24] and RotaSIIL® [25] . Recombinant vaccines could overcome the adverse consequences of live-attenuated vaccines. The common recombinant subunit vaccines are Hepatitis B vaccine which consists of hepatitis B virus surface antigen and recent recombinant vaccine against human papillomaviruses [26] . Novel next generation vaccination involving a rational design of B-and T-cell epitope-based vaccine have made substantial progress in the clinical trials. The recombinant epitope-based malaria vaccine that successfully reached phase-III trials might become the first commercial vaccine for parasitic disease [27] .

Immunoinformatic approaches have been used for prediction of an antigenic epitope for vaccine development and high-affinity antibodies for therapeutic and diagnostic applications [28, 29] . Some examples of computational immunoinformatic tools that has the potential to help experimental researchers to validate the in silico designed epitope-based vaccine includes but not limited to SARS-CoV-2 [30] , Zika virus [31] , and Nipah virus [32] . In silico identified protein regions with high probability of being effective epitopes might help in designing effective experimental assays with improved precision [33] . The present work involves the application of extensive computational immunoinformatic tools to identify potential B and T-cell epitopes to enable us to design a multi-epitope vaccine construct containing predicted antigenic fragments of rotavirus proteins. A tripeptide Arg-Gly-Asp (RGD) cell adhesion motif was added at the N-terminal end of the final vaccine construct to improve the immunogenicity. Allergenicity, antigenicity, epitope conservancy, structural modelling, docking and molecular dynamics simulation of vaccine constructs were carried out to ensure vaccine property of multi-epitope protein. Codon optimized multi-epitope vaccine antigens was expressed, and affinity purified in E. coli. The present observations of computational bioinformatics are expected to help researchers to select epitopes for further experimental validations and develop recombinant subunit vaccine against rotavirus.

The prototype simian agent 11 (SA11) was used as group A rotavirus reference strain to retrieve protein sequences in FASTA format due to availability of complete genome sequence (Table S1 ). Rotavirus pathogenesis is multifactorial and the outcome of disease is determined by both host and viral factors. Genetic analysis of selected virus reassortants identified several proteins of rotaviruses but not limited to VP3, VP4, VP6, VP7, NSP1, NSP2, NSP3, and NSP4 that are involved in virulence. The VP6 protein sequences of Adult diarrheal rotavirus (ADRV) and Cowden strain of porcine were included as group B and group C prototype strains. Among 12 rotavirus proteins, only 9 proteins were predicted as antigenic using VaxiJen v.2.0 with probability of antigenicity scores in the range of 0.4043-0.5734 (Table S1 ). Rotavirus NSP4 was predicted as non-antigen by VaxiJen which might be due to the limitation of server. NSP4 protein has pleiotropic properties including viral enterotoxin, intracellular role in viral replication and morphogenesis [34] . Recombinant NSP4 protein is known to induce age-dependent diarrhea in suckling mice mimicking a rotavirus disease caused during natural infection [35] . NSP4 and 9 other rotavirus proteins predicted as antigens was analyzed for the identification of B-and T-cell epitopes using well established immunoinformatic prediction methods ( Figure 1 ).

B cells are primarily involved in the production of antibodies to provide a protective immune defense against the foreign pathogens through the complement activation, antibody-mediated cytotoxicity, and Fc-mediated endocytosis. Additionally, B cells can exert antibodyindependent functions like antigen presentation, cytokine secretion, and immunoregulation [36] . The possible presence of linear B-cell epitopes in structural (VP2, VP3, VP4, VP6, VP7) and non-structural (NSP1, NSP2, NSP3, NSP4, NSP5) proteins were predicted by Bcepred using parameters such as antigenicity, surface accessibility, turns, flexibility and hydrophilicity. Bcepred prediction method uses a dataset of 1029 experimentally proved continuous B cell epitopes and 1029 non-epitopes covering a proteins derived from viruses, bacteria, protozoa and fungi. Therefore, Bcepred server is a reliable method used to predict the linear B-cell epitopes with an accuracy of 58.70% based on amino acid properties namely hydrophilicity, flexibility, polarity and exposed surface [37] . A total of 31 linear B-cell epitopes (9-15-mer length) were predicted for all proteins including 3 and 4 epitopes for group B and group C VP6 protein, respectively (Table 1) . We have developed a heat map to show the distribution of predicted linear B-cell epitopes across structural and nonstructural proteins of rotavirus ( Figure 2A ). We have selected 14 continuous B-cell epitopes with 2 epitopes each from VP6 group B and group C for inclusion in the vaccine construct based on epitope conservancy and agadir score of predicted epitopes. A maximum of 6 linear B-cell epitopes were predicted for VP4, 1 epitope was predicted for NSP5 and no epitope was predicted for NSP1 (Table S2a) . A conformational B-cell epitope is made of discontinuous stretches of amino acid residues that are tightly held together in tertiary conformation and as over 90% of epitopes are conformational epitopes [38] . Rotaviral proteins lacking crystallographic structures were modeled using multiple-threading approach server-I-TASSER. The c-score of best modeled structures were 0.010, -0.84, -1.41, -1.33, -1.71, -1.17 and -2.83 for VP2, VP3, VP4, VP7, NSP3, NSP4 and NSP5, respectively ( Figure S1 ). The best selected modeled structures were energy minimized and validated structures were used for prediction of conformational B-cell epitopes using four different independent tools to achieve maximum accuracy of computed epitope mapping; CBTOPE, DiscoTope 2.0, Ellipro and EPSVR (Table S2b ). The epitopes predicted by at least two different tools and found as antigenic, non-allergenic with agadir score and good conservancy across antigens have been selected as potential discontinuous B-cell epitope. Maximum 4 discontinuous 9 to 20-mer epitopes were predicted for VP4, while only 1 epitope each was predicted for NSP2, and VP4 ( Table 2 ). The localization of selected linear B-cell epitope in their native rotavirus protein structure was carried out using structural superimposition ( Figure S2 ). Agadir algorithm analyzes the stability of isolated α-helices and the alpha-helical tendency of the peptide in solution [39] . We found the epitope of rotavirus proteins VP3 (aa238-249), VP7 (aa168-184), NSP2 (aa298-312), NSP3 (aa108-120), and NSP5 (aa170-183) that are predicted to function as both linear and conformational B-cell epitopes (Table S2a and S2b).

In a given population some representative alleles called supertypes are found more frequently than others and have commonly shared binding specificity and these are of empirical use for epitope basedvaccine development [40] . 27 alleles (Table S3a ) of major Human Leukocyte Antigen class I (HLA-I) supertypes are known to have more than 97% population coverage (African Americans, Caucasians, Hispanics, Asians, North American Natives) [41, 42] . Similarly, for HLA-II, 27 alleles (Table S3b ) have been shown to provide more than 99% population coverage [43, 44] .

Cytotoxic T lymphocyte (CTL) belongs to the CD8þ subset of T cells that are associated with killing of cells-infected with intracellular virus, bacterial or protozoal parasites. CD8þ T cells bind epitopes that are presented by the MHC class I molecule while the CD4þ T cells recognize epitopes that are presented by MHC class I molecule. T cells are required for both cell-and antibody-mediated immune protection system. A total of 39 CTL epitopes (9-mer) were predicted for rotavirus proteome using three different tools namely IEDB Proteasomal cleavage/TAP transport/ MHC class I combined predictor, nHLAPred and RankPep (Table 1) . Similarly, a heat map was generated to indicate the distribution of predicted HLA-class I ( Figure 2B ) and II epitopes ( Figure 2C ) of structural and non-structural proteins of rotavirus. The highly conserved VP6 capsid protein sequences from group B and C rotaviruses were similarly analyzed and predicted 3 and 2 CTL epitopes, respectively ( Table 2 and  Table S4a ). We used NetMHCpan 3.1, ProPred and RankPep tools for prediction of HTL epitopes based on high affinity score. We have predicted and found total of 36 HTL epitopes (13-mer) for all proteins analyzed including one and three epitopes for VP6 of group B and C rotaviruses, respectively ( Table 2 and Table S4b ). Herein we reported prediction of CTL and HTL epitopes of rotavirus proteins using a total of 27 alleles of major HLA-I and HLA-II supertypes. Immunogenicity of CTL epitopes was predicted using IEDB method and epitopes that were assigned a higher score were selected indicating a greater probability to induce an immune response. Similarly, using IEDB tool we have predicted the immunogenicity of MHC class II epitopes and the results generated peptides of 15-mer amino acid residues with immunogenicity score ranging from 73-99 indicating non-immunogenic peptides ( Table S4b ). The observed poor predicted immunogenicity of CD4 epitopes could be due to the availability of only seven number of HLA alleles in the database tool [45, 46] . The probable cross-reactive allergenic peptides were predicted by online server AllerTOP v2.0. IEDB tool was used to analyze epitope conservancy with sequence identity threshold less than or equal to 100% and avoiding duplicated protein sequences. We have applied four criteria such as immunogenicity, non-allergenicity, conservancy and the same epitopes is being predicted by two of the three methods used to qualify the selection of predicted CTL and HTL epitopes for docking with MHC molecules (Table S4a and S4b).

The structure of peptide was generated by PEP-FOLD 2.0 and capping was performed. The PDB files of MHC I and MHC II molecules were retrieved from the Protein Data Bank and 27 HLA supertypes were used in the prediction of epitopes (Table S5a and S5b) . MHC I alleles lacking crystal structure was modelled using I-TASSER. Some of the MHC II alleles were used as reference crystallographic structures for docking with predicted T-cell epitopes. All MHC structures were energy minimized and MHC-peptide docking simulation was performed using ClusPro v.2.0 [47] . Interaction energy was analyzed by prodigy. CTL and HTL epitopes predicted as immunogenic/antigenic, non-allergenic and conserved across the antigens have been selected for designing multi-epitope vaccine based on docking score or free energy (Table S5a and S5b). We have selected the docking models of MHC-I/II and T-cell epitope complexes having the lowest binding energies. Conserved peptides with their interaction energies for structural and non-structural proteins in kcal mol À1 are given in Table S5a and S5b. Binding studies have shown that nonameric peptide is the most compatible length and binds MHC I molecules with the closed-ended peptide-binding cleft than peptides longer or shorter than nonameric peptide [48] . Anchor residues are generally hydrophobic in nature and found one at carboxyl terminus and second and third in amino-terminal end of the peptide (Table S4) . MHC II binding peptides has specific motif with a central core of 13 amino acid residues. Internal sequence stretches of 7-10 residues form the contact points with an N-terminal aromatic or hydrophobic residue, three hydrophobic residues at the centre and carboxyl end of the peptide (Table S4b ). This criterion was considered for the selection of final potent T-cell epitopes. 

A total of 10 multi-epitope vaccine constructs comprising of 69 amino acids (aa) through 576 aa consisting of 11 CTL, 11 HTL, 18 linear and 14 conformational B-cell epitopes have been described (Table 1 and Table 2 ). These predicted epitopes were derived from 5 structural (VP2, VP3, VP4, VP6 and VP7) and 4 non-structural proteins (NSP2, NSP3, NSP4 and NSP5). Linear B-cell epitopes were selected and included in the vaccine constructs based on (i) Agadir score (the helical content of peptide), (ii) conservancy (Table S2a) , (iii) surface localization of epitopes on the native protein of rotavirus ( Figure S2 ). Conformational B cell epitopes were selected based on prediction of the same epitope by (i) two prediction tools used, (ii) Agadir score and (iii) conservancy (Table S2b) . Similarly, T cell epitopes were included in the multi-subunit vaccine constructs based on prediction of the same epitope by (i) three prediction tools used, (ii) antigenicity/immunogenicity, (iii) non-allergenicity, (iv) Figure 2 . Summary of rotavirus protein-derived B-and T-cell epitopes. Heat map showing the distribution of (A) linear (continuous) B-cell epitopes, (B) HLA-class I and (C) II epitopes across the structural and non-structural protein sequences of rotavirus. Strong binding affinity epitopes with <0.5% rank and 2% rank, to HLA class I and class II, respectively, for each HLA molecule are represented here. Red color represents likely antigenic epitopes that were predicted using the methods described in Figure 1 . Each epitope in the vaccine construct was occupied by the appropriate linkers, adjuvant and CTL epitopes were combined by EAAAK rigid linker, intra-CTL and intra-HTL epitopes joint by AAY and KK cleavable linker, respectively, and B-cell epitopes were linked together by GGGGS flexible linker [30, 31, 32, 49] . Poly-Gly-rich flexible linkers are well characterized and generally do not affect the folding and function of fusion proteins [50] . Finally, vaccine construct was made containing N-terminal integrin binding motif (RGD) as adjuvant, CTL, HTL and B-cell epitopes (Figure 3 ). Rotavirus entry into the cell involves a multi-step process with sialic acid and integrins as viral receptors. The arginine-glycine-aspartate (RGD) motif has been shown to enhance immunogenicity and adjuvanicity in peptide antigens [51] . Since integrins are used as one of the receptors by rotavirus, RGD motif was selected as biological adjuvant to improve the immunogenicity of vaccine constructs. The rationale for a non-live subunit RV vaccine has no competition of uptake with enteric viruses in the gut, live-attenuated oral RV vaccines have lower rate of efficacies in developing countries and genetic background of the population is not critical (e.g. secretors/non-secretors) [11, 12] . We have designed a total of 10 possible multi-subunit vaccine constructs using the predicted B and T cell epitopes of RV Table 2 ). Some of the constructs were designed with predicted B-cell epitope with a long-term goal to express chimeric antigen to possibly develop rapid detection of rotavirus antigen in stool specimens.

Intestinal mucosal immunity mediated mainly by IgA antibodies is often associated with protective immunity during rotavirus reinfection. Rotavirus particle is made up of three layers of capsid proteins surrounding a genome of 11 segments of double-stranded RNA. The outer capsid layer is composed of VP4 and VP7 proteins that are mainly responsible for viral attachment and entry are often targeted for protective neutralizing antibodies during rotavirus infections [5, 52] . However, a non-neutralizing IgA monoclonal antibody directed against the VP6 protein have been shown to protect mice from rotavirus infection [53] . Studies on several non-replicating RV vaccines are being performed and assessed in various animal models. The expressed truncated VP6 and VP8 protein sub-units, bivalent vaccine (NSP4 & VP6) and ''virus-like particles" (VP2, VP4, VP6, and VP7) are being investigated as potential vaccine for rotavirus [54] . The results of preclinical studies have shown that majority of these potential vaccine candidates for rotavirus induces a strong immune responses and provides a protection against oral challenge with rotavirus strains in mice model [55, 56, 57] . VP6-specific polyclonal IgA inhibits RV replication at the transcription level by blocking channels on RV particles and preventing RV mRNA release [58] . The recent findings of an efficient intracellular neutralization mediated mainly by VP6-specific IgG and subsequent protection of mice against the challenge of rotavirus might have implications in developing next generation vaccine for rotavirus [59] .

All vaccine constructs were predicted as non-allergenic by Allertop v.2. Construct 1 was predicted as non-antigenic by Vexijen v.2.0 with a score (3.888) close to default threshold value of 4.0. Of 10 vaccine constructs, the antigenicity of construct 4 (NSP2/3/4/5), construct 5 (Table 3) . Various physicochemical parameters of vaccine constructs were analyzed by ProtParam. The final vaccine constructs were found moderately thermostable based on the aliphatic index scores (Table 3) . We found negative value of gravy scores suggesting the likelihood of multi-epitope vaccine being globular and hydrophilic in nature.

We used online server PSIPRED to predict the secondary structure of the final vaccine constructs. The predicted α-helix, β-sheets and random coil of vaccine constructs have been provided in Table 3 and Figure 4 & S3. Tertiary structure of the final vaccine constructs was modeled using I-TASSER, RaptorX and Phyre ( Figure 5 ). All the modeled structures were analyzed, and the common predicted structure was selected for further molecular simulation. I-TASSER modeled structures were found satisfactory for vaccine constructs (1, 2 

Further refinement and overall stability of multi-epitope subunit vaccine constructs were performed using molecular dynamics simulation in GROMACS, CHARMM27 force field and SPC/E water model as described previously. A plot of root square deviation (RMSD) against time reflects fluctuations generated within a time interval of 20 ns for all constructs and 40 ns for construct 5 having a predicted molecular weight of 62 kDa (Table 3) . RMSD value of multi-subunit vaccine backbone was predicted to be 0.2-0.7 nm (Figure 6 and Figure S4 ) and the structure validation of final vaccine was carried out using RAMPAGE server (Figure 7) . Table 4 provides the summary of distribution of amino acid residues in energetically favored area, allowed part and outlier region of vaccine constructs. The results of Ramachandran plots are suggestive of Table 3 . Physico-chemical parameter of final multi-epitope constructs. Number of residues, theoretical pI, molecular weight, aliphatic index, and grand average of hydrophobicity (GRAVY) by ProtParam. high structural quality due to the presence of a minimum steric atomic clashes between the residues in the refined vaccine constructs (Figure 7 and Table 4 ).

Cathepsin and carboxypeptidase are involved in MHC class II antigen presentation pathway through proteolytic cleavage of dibasic (RR, KK, KR or RK) sites present in the endocytosed proteins [61] . MHC class II molecules expressed by antigen presenting cells are associated with presentation of processed peptides to CD4þ T cells. Proteases that are involved in MHC class II antigen presentation pathway exhibits preferential cleavage of substrates containing hydrophobic motifs (AAY). We found that the cleavable linker residues (AAY and KK) in the multi-epitope subunit vaccines were accessible suggesting that the probability of T-cell epitopes presentation by MHC molecules as predicted by discovery studio (Figure 8) . Conformational B-cell epitopes that Table 4 . Summary of amino acid residues of vaccine constructs in the energetically favored, allowed and residues in the outlier region as analyzed by Physico-chemical parameter of final multi-epitope constructs. Table 4 . GLU75, ARG76, TYR145, VAL146, GLU147, THR148, ALA149,THR152, GLN220,  PHE216, TRP218, GLU219, THR221, VAL227, were included in the final vaccine construct was further verified with the help of four prediction servers -CBTOPE, Ellipro, Discotope and EPSVR. The results showed that the conformation epitopes were similarly predicted by CBTOPE, Ellipro, Discotope and EPSVR (Table S6) . We have predicted an additional discontinuous B-cell epitopes with the help of Ellipro ( Figure 9 and Table S7 ). ElliPro is a web-based server commonly used for prediction of an antibody epitopes in protein antigens [62, 63] .

Rotavirus entry is a multistep process involving the proteolytic cleavage of spike protein VP4 into two fragments VP5 and VP8, the interaction of these polypeptides and VP7 with integrins (αvβ3) and sialic acid including heat shock cognate protein [64, 65] . Modeled and refined structures of vaccine constructs was used for molecular docking with integrin receptors using ClusPro v.2.0 docking program (www.clusp ro.bu.edu) with default settings [47] . The interacting residues of four vaccine constructs with integrin receptor chain A and B is summarized in Table 5 . All the four vaccine models have shown interactions with chain A of integrin subunit (αIIbβ3 and αVβ3) receptors ( Figure 10 ) that are well known to mediate the entry of rotavirus involving VP4 and VP7 surface proteins [64, 65] .

Immunoinformatic approaches have commonly been used to identify potential B and T-cell epitopes that can help to induce humoral and cell-mediated immune responses. Neutralizing antibodies to VP4 and VP7 proteins are known to induce immunity against RV in natural infection in humans [5, 66] , anti-VP6 antibodies and CD4þ T cells have also been implicated in immune protection [67, 68] . In this work we have identified a total of 4 linear B-cell epitopes, of which two linear epitopes (aa117-128 and aa144-155) and 2 conformational B-cell epitopes (aa151-159, aa157-167) forms a part of secreted soluble form of NSP4 (Table 1 and Table 2 , Table S2a and S2b). It was previously shown that the secreted form of NSP4 (aa112-175) during rotavirus-infected cells was characterized as an enterotoxin of rotavirus protein. In a previous study an antibody to NSP4 aa112-175 was found to reduce the occurrence and severity of rotavirus-induced diarrhea in suckling mice pups [69] . It has been previously shown that a peptide (aa266-326) derived from VP7 can permeabilize artificial membranes leading to subsequent replication in virus-infected cells [70] . In silico analysis of rotavirus VP7 revealed the presence of potential linear (aa308-320), conformational B-cell (aa286-295) and CTL (aa316-324) epitopes in the (Table S2a and S2b) . Antibody to such peptides might block membrane crossing by non-enveloped rotavirus during infection. Rotavirus VP7 protein has well defined antigenic epitopes namely 7-1 and 7-2. 7-1 epitope is subdivided into 7-1a and 7-1b [71] . Region 7-1 that spans the inter-subunit boundary is reported as an immunodominant epitope. Antibodies that target region 7-1 of VP7 probably neutralized entry of rotavirus through stabilization of VP7 trimer and inhibition of uncoating signal required for VP4 structural rearrangement [71] . Cytotoxic T lymphocytes specific to rotavirus is reported to play an important role in the clearance of rotavirus infection. Rotavirus VP7 protein was shown to induce a class I MHC-restricted CTL response and the CTL epitopes (aa5-13, aa8-16 and aa31-40) were mapped to H1 and H2 signal sequence of protein [72] . Using immunoinformatic tools we have identified and mapped CTL (aa15-23) and HTL (aa13-25) epitopes that were previously characterized as MHC class I epitopes of VP7 (Table 2) . It has been shown that a synthetic peptide containing aa642 to 658 of VP5 can compete with the binding of the RRV to the heat shock cognate protein, HSC70 [73] . The VP5* subunit (aa308-310) of cleaved fragment of VP4 spike protein contains the α2β1 integrin (Asp-Gly-Glu) binding motif [74] . Synthetic peptides or antibodies to the regions spanning the predicted conformational (aa413-424) and linear B-cell epitope (aa657-667) of VP5 might provide a steric hindrance to rotavirus particle that uses α2β1 integrin as a receptor during entry ( Table 2 ). VP6 protein is the most abundant and highly conserved group specific antigen of rotavirus. The sequence between amino acid residues 48 to 75 of VP6 has previously been characterized as immunodominant based on reactivity of monoclonal antibodies [75] . In the present study, we have identified aa68-81 as potential HTL epitope spanning the previously predicted antibody binding epitope of VP6 protein (Table S4b ). In a previous study a synthetic peptide comprising of 14-amino acid spanning the region aa289-302 (RLSFQLVRPPNMTP) of VP6 protein was found to provide complete protection of mice against oral challenge of rotavirus [75] . Intriguingly, we predicted a 13-mer peptide (aa284-296) as potential HTL epitope of VP6 with a high conservancy (92%) among different rotavirus strains (Table 2) .

VP4 and VP7 proteins are the primary targets of vaccine development and neutralizing antibodies against VP4 and VP7 proteins do not prevent rotavirus reinfection suggesting the possible role of other structural and nonstructural proteins. Previous literature have observed the presence of NSP2-specific IgA and IgG antibodies in more than 75% of naturally rotavirus infected children [76] . The region of NSP2 that interacts with NSP5 protein include the C-terminal α-helix, the loop between aa 291 and 302, the loops between aa 64 to 68 and aa 179 to 183 and the helix between residues 232 and 251 [77] . Using phage display, antibody-binding epitope aa244-252 has been mapped to the region on NSP2 protein known to interact with NSP5 during viroplasm formation in virus-infected cells [77] . NSP2 aa298-312 (linear epitope) and aa298-313 (conformational B-cell epitope) predicted as B-cell epitope with a conservancy of around 89% (Table 1 and Table S2a ,b) might be useful for further experimental validations. The highly conserved Cterminal domain of rotavirus phosphoprotein NSP5 is required for viroplasm-like structure formation and is important for insolubility and hyperphosphorylation during rotavirus replication [78] . The findings of present in silico analysis revealed the presence of four overlapping HTL epitopes corresponding to NSP5 amino acid positions, aa175-193 using three independent prediction tools (Table S4b ). NSP5 aa170-183 and aa173-184 that have been found to contain predicted linear and conformational B-cell epitope, respectively, this region of NSP5 is also predicted as HTL epitopes (Table S2a and S2b) . Similarly, NSP5 aa2-10 (9-mer peptide) was predicted as CTL epitope, while the aa19-36 and aa66-85 of N-terminal region of NSP5 protein was predicted as conformational B-cell epitopes (Table S2b) . Interestingly, N-(aa1-33) and C-terminal region (aa 131-198) of NSP5 was previously shown to involved in interaction with NSP2 during rotavirus infection [79] . Rotavirus NSP2 and NSP5 are required for viroplasm formation and targeting both proteins may provide therapeutic implications during rotavirus-infected cells.

The vaccine construct was codon optimized as per E. coli (Strain ATCC 27325/DSM 5911/W3110/K12K12) strain using JCAT server and we found GC content of vaccine constructs 1 to 10 as 45.87%, 48.93%, 48.38%, 45.98%, 47.57%, 52.24%, 51.45, 47.67, 50.49 and 46.19%, respectively . GC content observed was in the range of 30-70% suggesting a minimal impact on transcriptional and translational efficiency. The value of codon adaptive index (CAI) for all vaccine constructs was 1 which is considered as good and satisfactory.

Of the 10 multi-subunit vaccines chimeric antigens designed, four constructs namely, construct 1, construct 2, construct 6 and construct 7 ( Table 2 ) have been synthesized and cloned into champion pET directional TOPO expression system (pET100/D-TOPO) using manufacturer instructions (Thermofischer Scientific). The recombinant clones were verified by PCR using gene specific primers ( Figure 11A ). We found optimum expression and solubility of N-terminal 6xHis-tagged multisubunit chimeric antigens induced with 200 μM concentration of IPTG at 25 C temperature for 16 h ( Figure 11B ). Silver stained-SDS-PAGE gel electrophoresis confirmed the homogeneity of affinity purified chimeric proteins ( Figure 11C and Figure S5 ) and different concentrations of BSA was loaded to determine the approximate concentration of purified proteins estimated using Bradford assay.

In this study, we have predicted and identified immuno-dominant antigenic fragments derived from 9 protein sequences of rotavirus structural (VP2, VP3, VP4, VP6 and VP7) and non-structural proteins (NSP2, NSP3, NSP4 and NSP5) that might have the abilities to induce immunity against rotavirus infection. As a part of our preliminary work we have cloned and expressed the multi-epitope vaccine constructs in E. coli and need to be experimentally validated for further use. Although the findings of present study is mainly based on computational prediction algorithms, but the immune epitopes presented herein will provide a platform for future experimental validations that may help to design peptide-based vaccine against rotavirus.

In this study, the prototype simian group A rotavirus SA11 strain was used as reference strain to download sequences of structural (VP1, VP2, VP3, VP4, VP6 and VP7) and non-structural proteins (NSP1, NSP2, NSP3, NSP4 and NSP5); VP6 protein sequences of Adult diarrheal rotavirus (ADRV) and Cowden strain of porcine were included as group B and group C reference strains. The accession numbers of rotavirus proteins used for various bioinformatics analyses have been given in Table S1 . All retrieved rotavirus protein sequence was analyzed for antigenicity using VaxiJen v2.0 server (http://ddg-pharmfac.net/vaxijen). VaxiJen is the first server used for prediction of whole protein antigenicity in an alignment-independent manner with high prediction accuracy of 70%-89% [80] .

Antigenic/immunogenic epitopes are specific part of an antigens that are recognized by the immune B-cell antibodies. We have predicted linear B-cell epitope using Bcepred server [81, 82] . Bcepred predict B-cell epitopes based on combination of four parameters such as flexibility, hydrophilicity, polarity, and exposed surface with a prediction accuracy of about 58.7% (http://crdd.osdd.net/raghava/bcepred). We used full-length or partial crystallographic {VP4 {VP8 (PDB ID: 2P3I), VP5 (PDB ID: 2B4H)}, VP6 (PDB ID: 1QHD), VP7 (PDB ID: 3FMG), NSP2 (PDB ID: 1L9V), NSP3 (PDB ID: 1KNZ)} and modelled structures of rotavirus proteins to identify and predict a conformational B-cell epitopes [81] . Four different servers have been used to develop a reliable identification of conformational B-cell epitopes of rotavirus proteins [31, 32, 33, 62] . CBTOPE server (http://crdd.osdd.net/raghava/cbtope) predicts B-cell epitope of an antigen using SVM-based model [83] . B-cell epitope prediction using DiscoTope 2.0 server (http://tools.iedb.org/discotope/) is based on estimation of surface accessibility with a default threshold setting value of -3.7. ElliPro (http://tools.iedb.org/ellipro/)predicts B-cell epitopes using the structure of an antigen. EPSVR (http://sy sbio.unl.edu/EPSVR/) uses a Support Vector Regression (SVR) method to predict B-cell epitopes and shown to exhibit high performance with AUC value 0.597 as compared to the existing prediction servers [84] . Agadir score (http://agadir.crg.es/)was calculated for selection of potent epitopes based on its helical content [85] .

Cytotoxic T lymphocytes (CTL) epitopes of 9-mer peptide length were predicted using three different tools [81] . Proteasomal cleavage/TAP transport/MHC class I combined predictor (http://tools.iedb.org/p rocessing) is a tool that predicts CTL epitopes based on combination of prediction scores obtained for each of proteasomal processing, TAP transport, and MHC binding . The top 2% binders with an IC 50 less than or equal to 500nM was considered [64] . nHLAPred (http://crdd.osdd.net/raghava /nhlapred) predicts MHC I binding peptide using a neural network method [86] . Rankpep (http://imed.med.ucm.es/tools/rankpep.html)is used for prediction of peptides binding to MHC I and MHC II molecules using position specific scoring matrices and the top 2% MHC binders were selected [87] . Similarly, helper T-cell (HTL) epitopes were identified by NetMHCIIpan 3.1 (http://cbs.dtu.dk/services/NetMHCIIp an-3.1/). The threshold value for peptides with strong binding affinity was set as top 2%. ProPred (http://crdd.osdd.net/raghava/propred/) have been used to identify 9-mer promiscuous MHC II peptides based on quantitative matrices and the top 3% predicted peptides were selected as best binders [88] . Rankpep server predicted MHC class-II binding peptides top 5% best binders were selected in this study. A total of 27 HLA supertypes alleles with maximum population coverage (approximately >97%) were selected to identify and predict MHC I and II binding peptides [40, 41, 42, 43, 44] .

Antigenicity of predicted epitopes in our vaccine constructs were assessed by VaxiJen v2.0. The identification of immunogenic epitopes is of great importance in understanding cellular immune responses and vaccine development. IEDB Class I immunogenicity tool (http://tools.iedb.org/immunogenicity/)was used to characterize the immunogenic potential of predicted 9-mer MHC I binding peptide [89] . We have predicted the immunogenicity (http://tools.iedb.org/CD4epi score) of MHC II binding epitopes using 7-allele method, immunogenicity method and combined method [45, 46] . AllerTOP v2.0 (http://www.ddg-pharmfac.net/AllerTOP/) was used to predict the allergenic properties and the route of exposure of vaccine construct [85] . A web-based IEDB tool (http://tools.iedb.org/conservancy/)was used to predict the conservancy of epitopes that were included in the vaccine constructs [90] .

It is important to determine the strength of interaction of peptide-MHC molecules and the T-cell receptors. Molecular docking approach was used to identify and select the best CTL/HTL epitopes binding to MHC molecules. The 3D structure of peptide was generated by PEP-FOLD 2.0 (http://bioserv.rpbs.univ-paris-diderot.fr/services/PEP-FOLD/) and N-and C-terminals ends were capped [91] . We retrieved the PDB files of MHC molecules from Protein Data Bank for docking purpose. MHC allele lacking a crystal structure was modelled by I-TASSER (https://zhanglab. ccmb.med.umich.edu/I-TASSER/). MHC-peptide docking simulation was performed using ClusPro v.2.0 docking program (www.cluspro.bu.edu) with default settings [47] . Interaction energy was analyzed by prodigy (http://milou.science.uu.nl/services/PRODIGY/) [92] .

Using the information of predicted epitopes, a multi-epitope-based vaccine was designed using high scoring peptide sequence consisting of T-and B-cell epitopes. Predicted immune epitopes were joined by cleavable and flexible linkers [30, 31, 62] . Integrin binding motif (RGD) fused with EAAAK linker was added as adjuvant and forms the component of final multi-epitope vaccine [39] .

Physiochemical properties of vaccine constructs were analyzed using ProtParam [93] . Secondary structure of designed vaccine was predicted using the sequence of amino acid as input data by PSIPRED v3.3 (http:// bioinf.cs.ucl.ac.uk/psipred/). Position-specific iterated BLAST (PSI--BLAST) was employed to select sequences exhibiting homology to vaccine constructs [94] . Modeling of vaccine constructs was done by I-TASSER [95] , Phyre [96] and RaptorX. The best structures selected based on similarity of structure modelled by all three methods (I-TASSER, RaptorX, Phyre2) was used for validation and molecular dynamics simulation. We validated modelled structure by RAMPAGE server that provides a Ramachandran plots for glycine and proline amino acid residues. Ramachandran plot shows the distribution of torsion angles [psi (ψ) and phi (ϕ)] in a protein structure based on calculated van der Waal radius of the side chain [97] .

Molecular dynamics (MD) is a computer simulation method that provides detailed information on the fluctuations and conformational changes of atoms and molecules. MD simulation of epitope-based vaccine was performed using GROMACS, v4.6.5 [98] . We used single point charge water molecules and CHARMM27 force field to determine the intermolecular interactions. Solvation was done in a cubic boxtype and appropriate number of chloride and sodium ions was used to neutralize peptide charges. Energy minimization was done using the steepest decent algorithm for 50000 steps with the maximum force of 1000 kJ/mol/nm. Equilibration of NVT (constant Number of particles, Volume and Temperature) and NPT (constant Number of particle, Pressure and Temperature) ensemble was done for 100 ps using Particle Mesh Ewald algorithm. After equilibrations of NVT at 300 K and NPT at 1 bar and production MD run was performed for 20 ns using LINCS (Linear Constant Solver) algorithm [98] . Root mean square deviation and root mean square fluctuation were performed to calculate standard deviation and fluctuation of the protein backbone with respect to time.

4.9. Codon optimization, synthesis, expression, and affinity purification of chimeric constructs in E. coli Codon optimized epitope-based vaccine namely constructs 1, 2, 6 and 7 was cloned into the Champion pET directional TOPO expression cloning vector (pET100/D-TOPO, Thermofischer Scientific) to achieve high level expression in E. coli. Expression of N-terminal 6xHis-tagged multi-subunit chimeric antigens was induced at culture OD 600 of 0.6 Y.D. Devi et al.

Heliyon 6 (2020) e05760

using different concentration of IPTG at 18 C, 25 C and 37 C. Ni 2þaffinity purification of soluble protein was carried out using Tris-NaCl buffer with 5 mM imidazole in the binding buffer and eluted with 250 mM imidazole, pH 7.4. The purified protein was dialyzed in a Tris buffer supplemented with NaCl. The purity of protein was analyzed on silverstained SDS-PAGE and different concentrations of BSA was loaded to determine the approximate concentration of purified proteins estimated using Bradford assay.

Author contribution statement Yengkhom Damayanti Devi: Performed the experiments; Analyzed and interpreted the data; Wrote the paper. Arpita Devi, Hemanga Gogoi, Bondita Dehingia: Performed the experiments.

Robin Doley: Contributed reagents, materials, analysis tools or data. Alak Kumar Buragohain, Ch. Shyamsunder Singh, Partha Pratim Borah, C Durga Rao, Pratima Ray, George M. Varghese, Sachin Kumar: Analyzed and interpreted the data.

Nima D Namsa: Conceived and designed the experiments; Analyzed and interpreted the data; Contributed reagents, materials, analysis tools or data; Wrote the paper. 

Data included in article and supplementary material.

Prevalence of rotavirus on high-risk fomites in daycare facilities

Rotavirus proteins: structure and assembly

Fields virology

VP4-and VP7-specific antibodies mediate heterotypic immunity to rotavirus in humans

Uniformity of rotavirus strain nomenclature proposed by the rotavirus classification working group (RCWG)

Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis

Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine

Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis

European society for paediatric infectious diseases consensus recommendations for rotavirus vaccination in europe: update

Effect of human rotavirus vaccine on severe diarrhea in African infants

Effectiveness of a live oral human rotavirus vaccine after programmatic introduction in Bangladesh: a clusterrandomized trial

World Health Organisation (WHO), Immunization, Vaccines and Biologicals-Rotavirus

Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial

Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian children in the second year of life

Stability of heat stable, live attenuated Rotavirus vaccine (ROTASIIL®)

SII BRV-PV author group, A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants

Efficacy of a low-cost, heat-stable oral rotavirus vaccine in Niger

Multiple introductions and antigenic mismatch with vaccines may contribute to increased predominance of G12P[8] rotaviruses in the United States

Rotavirus vaccines: effectiveness, safety, and future directions

Risk of intussusception following rotavirus vaccination: an evidence based meta-analysis of cohort and case-control studies

Value of post-licensure data on benefits and risks of vaccination to inform vaccine policy: the example of rotavirus vaccines

More on RotaShield and intussusception: the role of age at the time of vaccination

Efficacy of a monovalent humanbovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial

A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants

Recombinant vaccines and the development of new vaccine strategies, Braz

Recombinant and epitope-based vaccines on the road to the market and implications for vaccine design and production

An overview of bioinformatics tools for epitope prediction: implications on vaccine development

Use of a synthetic biosensor for neutralizing activity-biased selection of monoclonal antibodies against atroxlysin-I, an hemorrhagic metalloproteinase from Bothrops atrox snake venom

Exploring the SARS-CoV-2 structural proteins for multi-epitope vaccine development: an in-silico approach

Designing B-and T-cell multiepitope-based subunit vaccine using immunoinformatics approach to control Zika virus infection

Strategic development of a next-generation multi-epitope vaccine to prevent Nipah virus zoonotic infection

Identification of conformational B-cell Epitopes in an antigen from its primary sequence

The rotavirus enterotoxin NSP4 mobilizes intracellular calcium in human intestinal cells by stimulating phospholipase C-mediated inositol 1,4,5-trisphosphate production

Rotavirus toxin NSP4 induces diarrhea by activation of TMEM16A and inhibition of Naþ absorption

The role of B cells in the pathogenesis of graft-versus-host disease

BcePred: prediction of continuous B-cell epitopes in antigenic sequences using physico-chemical properties

Prediction of residues in discontinuous B cell epitopes using protein 3D structures

Elucidating the folding problem of helical peptides using empirical parameters

Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations

Fern andez-Viña, Analysis of the frequencies of HLA-A, B, and C alleles and haplotypes in the five major ethnic groups of the United States reveals high levels of diversity in these loci and contrasting distribution patterns in these populations

Minimal phenotype panels. A method for achieving maximum population coverage with a minimum of HLA antigens

Accurate pan-specific prediction of peptide-MHC class II binding affinity with improved binding core identification

Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8þ T cells

Predicting HLA CD4 immunogenicity in human populations

Development and validation of a broad scheme for prediction of HLA class II restricted T cell epitopes

The ClusPro web server for protein-protein docking

Structure of peptides associated with MHC class I molecules

Intranasal vaccination against HIV-1 with adenoviral vector-based nanocomplex using synthetic TLR-4 agonist peptide as adjuvant

Transfer of a beta-turn structure to a new protein context

RGD motif enhances immunogenicity and adjuvanicity of peptide antigens following intranasal immunization

Mechanisms of protection against rotavirus infection and disease

Inhibition of rotavirus replication by a nonneutralizing, rotavirus VP6-specific IgA mAb

The rotavirus vaccine development pipeline

Protection against live rotavirus challenge in mice induced by parenteral and mucosal delivery of VP6 subunit rotavirus vaccine

VP6: a candidate rotavirus vaccine

Oral administration of a seed-based bivalent rotavirus vaccine containing VP6 and NSP4 induces specific immune responses in mice

Human rotavirus VP6-specific antibodies mediate intracellular neutralization by binding to a quaternary structure in the transcriptional pore

Intracellular neutralisation of rotavirus by VP6-specific IgG

Template-based protein structure modeling using the RaptorX web server

Antigen processing and T cell repertoires as crucial aleatory features in induction of autoimmunity

Exploring Leishmania secretory proteins to design B and T cell multi-epitope subunit vaccine using immunoinformatics approach

ElliPro: a new structure-based tool for the prediction of antibody epitopes

Integrin alpha (v) beta (3) mediates rotavirus cell entry

VP7 mediates the interaction of rotaviruses with integrin alphavbeta3 through a novel integrin-binding site

Intranasal or oral immunization of inbred and outbred mice with murine or human rotavirus VP6 proteins protects against viral shedding after challenge with murine rotaviruses

CD4 T cells are the only lymphocytes needed to protect mice against rotavirus shedding after intranasal immunization with a chimeric VP6 protein and the adjuvant LT(R192G)

A functional NSP4 enterotoxin peptide secreted from rotavirus-infected cells

A peptide derived from the rotavirus outer capsid protein VP7 permeabilizes artificial membranes

Structure of rotavirus outer-layer protein VP7 bound with a neutralizing Fab

Rotavirusspecific cytotoxic T lymphocytes recognize overlapping epitopes in the aminoterminal region of the VP7 glycoprotein

Interaction of rotaviruses with Hsc70 during cell entry is mediated by VP5

Rotavirus spike protein VP5* binds alpha2beta1 integrin on the cell surface and competes with virus for cell binding and infectivity

Localization of group-specific epitopes on the major capsid protein of group A rotavirus

Non-structural protein NSP2 induces heterotypic antibody responses during primary rotavirus infection and reinfection in children

Cryoelectron microscopy structures of rotavirus NSP2-NSP5 and NSP2-RNA complexes: implications for genome replication

Identification of an antibody-binding epitope on the rotavirus A non-structural protein NSP2 using phage display analysis

Phosphorylation generates different forms of rotavirus NSP5

VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines

BcePred: prediction of continuous B-cell epitopes in antigenic sequences using physico-chemical properties

Reliable B cell epitope predictions: impacts of method development and improved benchmarking

EPSVR and EPMeta: prediction of antigenic epitopes using support vector regression and multiple server results

Modeling the MHC class I pathway by combining predictions of proteasomal cleavage, TAP transport and MHC class I binding

Predicting HLA CD4 immunogenicity in human populations

AllerTOP -a server for in silico prediction of allergens

A hybrid approach for predicting promiscuous MHC class I restricted T cell epitopes

Prediction of MHC class I binding peptides using profile motifs

ProPred: prediction of HLA-DR binding sites

Properties of MHC class I presented peptides that enhance immunogenicity

Development of an epitope conservancy analysis tool to facilitate the design of epitope-based diagnostics and vaccines

Improved PEP-FOLD approach for peptide and miniprotein structure prediction

PRODIGY: a web server for predicting the binding affinity of protein-protein complexes

Protein identification and analysis tools on the ExPASy server

The PSIPRED protein structure prediction server

I-TASSER: a unified platform for automated protein structure and function prediction

The Phyre2 web portal for protein modeling, prediction and analysis

Structure validation by Calpha geometry: phi,psi and Cbeta deviation

Gromacs 4.5: a high-throughput and highly parallel open source molecular simulation toolkit

The authors declare no conflict of interest.

Supplementary content related to this article has been published online at https://doi.org/10.1016/j.heliyon.2020.e05760.